Cargando…
Prediction of sarcopenia using a battery of circulating biomarkers
Loss of muscle mass and strength with aging, termed sarcopenia is accelerated in several comorbidities including chronic heart failure (CHF) and chronic obstructive pulmonary diseases (COPD). However, the effective circulating biomarkers to accurately diagnose and assess sarcopenia are not known. We...
Autores principales: | Qaisar, Rizwan, Karim, Asima, Muhammad, Tahir, Shah, Islam, Khan, Javaidullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060253/ https://www.ncbi.nlm.nih.gov/pubmed/33883602 http://dx.doi.org/10.1038/s41598-021-87974-6 |
Ejemplares similares
-
Circulating MicroRNAs as Biomarkers of Accelerated Sarcopenia in Chronic Heart Failure
por: Qaisar, Rizwan, et al.
Publicado: (2021) -
Circulating Biomarkers of Accelerated Sarcopenia in Respiratory Diseases
por: Qaisar, Rizwan, et al.
Publicado: (2020) -
Prediction of Sarcopenia Using Multiple Biomarkers of Neuromuscular Junction Degeneration in Chronic Obstructive Pulmonary Disease
por: Karim, Asima, et al.
Publicado: (2021) -
The coupling between sarcopenia and COVID-19 is the real problem
por: Qaisar, Rizwan, et al.
Publicado: (2021) -
Circulating Biomarkers of Handgrip Strength and Lung Function in Chronic Obstructive Pulmonary Disease
por: Qaisar, Rizwan, et al.
Publicado: (2020)